Drug General Information (ID: DDIDIAVL2J)
  Drug Name Ketamine Drug Info Safinamide Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Analgesics Dopaminergic Antiparkinsonism Agents
  Structure

 Mechanism of Ketamine-Safinamide Interaction (Severity Level: Moderate)
     Additive hypertensive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Ketamine Safinamide
      Mechanism 1 Hypertensive effects Hypertensive effects
      Key Mechanism Factor 1
Factor Name Hypertensive effects
Factor Description Hypertension is defined as a blood pressure reading above a prescribed limit (130/90 mmHg). Most people with hypertension have no signs or symptoms; others may experience: severe headache, shortness of breath, nosebleeds, severe anxiety, and feeling a tingling sensation in the neck or head.
      Mechanism Description
  • Additive hypertensive effects by the combination of Ketamine and Safinamide 
     Increased risk of rapid heart rate Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Ketamine Safinamide
      Mechanism 2 Tachycardia Tachycardia
      Key Mechanism Factor 2
Factor Name Tachycardia
Factor Description A faster-than-normal heart rate, but the heart is beating normally. Tachycardia may not cause any symptoms or complications, but if left untreated, some forms of tachycardia can lead to serious health problems, including heart failure, stroke, or sudden cardiac death.
      Mechanism Description
  • Increased risk of rapid heart rate by the combination of Ketamine and Safinamide 

Recommended Action
      Management Close monitoring of vital signs, including blood pressure and heart rate is recommended whenever ketamine is used concomitantly with direct or indirect acting sympathomimetics or vasopressin.

References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Product Information. Ketalar (ketamine). JHP Pharmaceuticals, Saddle River, NJ.